News

Idaho’s health insurance plan for state employees will stop covering prescription medication for weight loss on Nov. 1. In a ...
The pivot to FDA-approved generics as patents expire in various countries follows a year of soaring demand for the branded ...
The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...
Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...
Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.
I’m calling for this decision to be immediately reversed so that the drug is financially accessible to those of us who have ...
To get to the, well, bottom of things, PRIDE spoke with medical experts Dr. David Shafer, a double board-certified plastic ...
Losing weight can be emotional, but the Cork plant making the active ingredient in weight-loss drug Mounjaro has no room for ...
BRITS have been warned about a surge in black market demand for a powerful new drug dubbed the “Godzilla” of fat jabs.
Hundreds of sham social media profiles and websites are selling the fake drugs, the EMA said. Fake weight-loss drugs are ...
Israeli drugmaker Teva Pharmaceutical Industries has announced US Food and Drug Administration (FDA) approval and launch of a generic version of Saxenda (liraglutide injection).
With Novo Nordisk’s semaglutide patent set to expire in China in 2026, local companies are readying generics to grasp market ...